Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...
The Digital Greenwich Connect (DGC) project, which is as Joint Venture (JT) between DG Cities, the Royal Borough of Greenwich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback